Skip to main content
. 2018 Jun 28;5(3):ENEURO.0164-18.2018. doi: 10.1523/ENEURO.0164-18.2018

Table 5.

Effects of LY341495 (mGluR2/3 antagonist) on response latencies

Response latency Dose Mean (ms) SE N
Sample phase
F(3,27) = 2.017, p = 0.185
Vehicle 1915.99 447.33 10
5 ng 3014.86 971.06 10
50 ng 2948.58 1379.83 10
500 ng 4907.86 2351.06 10
Matching phase
F(3,27) = 1.0, p = 0.408
Vehicle 1059.35 106.66 10
5 ng 1191.25 120.88 10
50 ng 1108.37 83.11 10
500 ng 1173.37 104.58 10